Report Search Results	As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 36) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 9-Feb-10 New Constructs, LLC N/A ITMN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10     View Abstract 9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ITMN: the economy's impact on ITMN's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: INTERMUNE -- ITMN 1 $4     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: IDIX , ITMN , ISIS , MYGN , ORXE , OSIP -- DRUGS 3 $4     View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of INTERMUNE INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20     View Abstract 2-Feb-10 Rapid Ratings Rapid Ratings INTERMUNE INC rated sell (2010-02-02) (US$665) 8 $665     View Abstract 1-Feb-10 Zacks Investment Research Inc. N/A INTERMUNE INC (ITMN) Zacks Company Snapshot 1 $10     View Abstract Next 20

Brokerage Reports (Showing 1 to 3 of 3) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 1-Feb-10 Roth Capital Partners, Inc. Edward Nash Achillion Corporate Update: Achillion Growing On All Fronts 6 $25     View Abstract 13-Jan-10 Roth Capital Partners, Inc. Research Department Morning Call Summary 10 $25     View Abstract 12-Jan-10 Roth Capital Partners, Inc. Edward Nash Positive Data Unrewarded, Creates A Strong Buying Opportunity 5 $10     View Abstract

Independent Reports (Showing 1 to 10 of 33) Release Date  Contributor Author Title Pages Price More Info 9-Feb-10 New Constructs, LLC N/A ITMN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract 9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ITMN: the economy's impact on ITMN's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: INTERMUNE -- ITMN 1 $4 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: IDIX , ITMN , ISIS , MYGN , ORXE , OSIP -- DRUGS 3 $4 View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of INTERMUNE INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract 2-Feb-10 Rapid Ratings Rapid Ratings INTERMUNE INC rated sell (2010-02-02) (US$665) 8 $665 View Abstract 1-Feb-10 Zacks Investment Research Inc. N/A INTERMUNE INC (ITMN) Zacks Company Snapshot 1 $10 View Abstract Next 20